Cargando…

Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer

BACKGROUND: The incidence of lymph node metastases is closely related to the T-stage, and therefore Eastern guidelines advice a D1 lymphadenectomy for early gastric cancer and a D2 lymphadenectomy for advanced gastric cancer. The aim of this study was to compare the lymph node metastases rate in the...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Mees Hendrik Siert, Gisbertz, Suzanne Sarah, van Berge Henegouwen, Mark Ivo, Draaisma, Werner Adriaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459217/
https://www.ncbi.nlm.nih.gov/pubmed/36092353
http://dx.doi.org/10.21037/jgo-22-147
_version_ 1784786458701201408
author de Jong, Mees Hendrik Siert
Gisbertz, Suzanne Sarah
van Berge Henegouwen, Mark Ivo
Draaisma, Werner Adriaan
author_facet de Jong, Mees Hendrik Siert
Gisbertz, Suzanne Sarah
van Berge Henegouwen, Mark Ivo
Draaisma, Werner Adriaan
author_sort de Jong, Mees Hendrik Siert
collection PubMed
description BACKGROUND: The incidence of lymph node metastases is closely related to the T-stage, and therefore Eastern guidelines advice a D1 lymphadenectomy for early gastric cancer and a D2 lymphadenectomy for advanced gastric cancer. The aim of this study was to compare the lymph node metastases rate in the stations dissected with a D2-lymphadenectomy (stations 8–12) yet spared with a D1-lymphadenectomy, between different T-stages in a Western patient cohort. METHODS: For this retrospective study, patients who underwent a gastrectomy in the Amsterdam University Medical Center (UMC), location Academic Medical Center (AMC), between 2011 and 2016 were identified from a prospectively maintained database. The primary outcome was to compare the rate of lymph node metastases in station 8–12 between different cT-stages. RESULTS: One hundred twelve patients met our inclusion criteria. There were no positive lymph nodes in the lymph nodes stations 8–12 in cT1 and (y)pT1-stage tumors. The more advanced cT2-4 and (y)pT2-4 stage tumors show a high metastases rate (11.1% to 40.0%) in the lymph node stations 8–12. CONCLUSIONS: The results from this study endorse the Japanese Gastric Cancer Guideline; in early gastric cancer, a D1 lymphadenectomy is sufficient, while in advanced gastric cancer a D2 lymphadenectomy should be performed.
format Online
Article
Text
id pubmed-9459217
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-94592172022-09-10 Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer de Jong, Mees Hendrik Siert Gisbertz, Suzanne Sarah van Berge Henegouwen, Mark Ivo Draaisma, Werner Adriaan J Gastrointest Oncol Original Article BACKGROUND: The incidence of lymph node metastases is closely related to the T-stage, and therefore Eastern guidelines advice a D1 lymphadenectomy for early gastric cancer and a D2 lymphadenectomy for advanced gastric cancer. The aim of this study was to compare the lymph node metastases rate in the stations dissected with a D2-lymphadenectomy (stations 8–12) yet spared with a D1-lymphadenectomy, between different T-stages in a Western patient cohort. METHODS: For this retrospective study, patients who underwent a gastrectomy in the Amsterdam University Medical Center (UMC), location Academic Medical Center (AMC), between 2011 and 2016 were identified from a prospectively maintained database. The primary outcome was to compare the rate of lymph node metastases in station 8–12 between different cT-stages. RESULTS: One hundred twelve patients met our inclusion criteria. There were no positive lymph nodes in the lymph nodes stations 8–12 in cT1 and (y)pT1-stage tumors. The more advanced cT2-4 and (y)pT2-4 stage tumors show a high metastases rate (11.1% to 40.0%) in the lymph node stations 8–12. CONCLUSIONS: The results from this study endorse the Japanese Gastric Cancer Guideline; in early gastric cancer, a D1 lymphadenectomy is sufficient, while in advanced gastric cancer a D2 lymphadenectomy should be performed. AME Publishing Company 2022-08 /pmc/articles/PMC9459217/ /pubmed/36092353 http://dx.doi.org/10.21037/jgo-22-147 Text en 2022 Journal of Gastrointestinal Oncology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
de Jong, Mees Hendrik Siert
Gisbertz, Suzanne Sarah
van Berge Henegouwen, Mark Ivo
Draaisma, Werner Adriaan
Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
title Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
title_full Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
title_fullStr Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
title_full_unstemmed Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
title_short Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
title_sort lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459217/
https://www.ncbi.nlm.nih.gov/pubmed/36092353
http://dx.doi.org/10.21037/jgo-22-147
work_keys_str_mv AT dejongmeeshendriksiert lymphnodemetastasesrateoflocoregionalandnonlocoregionallymphnodestationsingastriccancer
AT gisbertzsuzannesarah lymphnodemetastasesrateoflocoregionalandnonlocoregionallymphnodestationsingastriccancer
AT vanbergehenegouwenmarkivo lymphnodemetastasesrateoflocoregionalandnonlocoregionallymphnodestationsingastriccancer
AT draaismawerneradriaan lymphnodemetastasesrateoflocoregionalandnonlocoregionallymphnodestationsingastriccancer